Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has successfully returned the temporary use of RMB350 million from the Net Proceeds, initially allocated for cash flow purposes, back to the company’s Designated Accounts within the agreed 12-month period. The Placement Agent has been notified of this completion. This financial maneuver demonstrates the company’s ability to manage its funds efficiently and honor its financial commitments.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
